Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Aug 6, 2014 van plew daniel p Officer Disposition (Non Open Market) 8,194 336.11
Feb 27, 2014 brown michael s Director Sell 1,000 335.00
Mar 17, 2014 brown michael s Director Automatic Sell 2,000 333.42 - 336.49
Feb 18, 2014 terifay robert j Officer Sell 12,865 331.66 - 333.79
Aug 6, 2014 goldstein joseph l Director Sell 2,000 331.20
Mar 11, 2014 sanofi Beneficial Owner (10% or more) Buy 180,710 328.82 - 335.68
Mar 17, 2014 sanofi Beneficial Owner (10% or more) Buy 60,128 328.32 - 328.86
Mar 3, 2014 sanofi Beneficial Owner (10% or more) Buy 251,594 328.00 - 339.94
Feb 21, 2014 goldberg murray a Officer Automatic Sell 21,258 327.84 - 339.31
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 241,818 327.77 - 339.06
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Mar 14, 2014 sanofi Beneficial Owner (10% or more) Buy 55,583 326.77 - 329.00
Mar 19, 2014 sanofi Beneficial Owner (10% or more) Buy 9,746 326.44 - 328.67
Feb 20, 2014 goldberg murray a Officer Automatic Sell 29,394 326.05
Mar 20, 2014 sanofi Beneficial Owner (10% or more) Buy 57,957 325.94 - 328.93
Mar 12, 2014 sanofi Beneficial Owner (10% or more) Buy 220,995 325.40 - 339.27
Mar 10, 2014 sanofi Beneficial Owner (10% or more) Buy 199,822 325.34 - 332.26
Feb 11, 2014 vagelos p roy Officer Automatic Sell 11,475 325.10
Feb 11, 2014 mccorkle douglas s Officer Automatic Sell 5,819 325.00
Feb 18, 2014 aberman michael s Officer Automatic Sell 3,648 324.81 - 334.24
Showing 21-40 of 822 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)